| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4569177
Max Phase: Preclinical
Molecular Formula: C17H10Cl4N4O2S
Molecular Weight: 476.17
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: O=C(Nc1nc2ccc(Cl)cc2s1)NN1C(=O)C(Cl)C1c1ccc(Cl)cc1Cl
Standard InChI: InChI=1S/C17H10Cl4N4O2S/c18-7-1-3-9(10(20)5-7)14-13(21)15(26)25(14)24-16(27)23-17-22-11-4-2-8(19)6-12(11)28-17/h1-6,13-14H,(H2,22,23,24,27)
Standard InChI Key: HLULTZRXKIQNBX-UHFFFAOYSA-N
Associated Targets(non-human)
Mus musculus 284745 Activities
4-aminobutyrate aminotransferase, mitochondrial 4 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 476.17 | Molecular Weight (Monoisotopic): 473.9279 | AlogP: 5.48 | #Rotatable Bonds: 3 |
| Polar Surface Area: 74.33 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 7.56 | CX Basic pKa: | CX LogP: 5.51 | CX LogD: 5.30 |
| Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.39 | Np Likeness Score: -1.50 |
References
| 1. Jamal Gilani S, Zaheen Hassan M, Sarim Imam S, Kala C, Prakash Dixit S.. (2019) Novel benzothiazole hydrazine carboxamide hybrid scaffolds as potential in vitro GABA AT enzyme inhibitors: Synthesis, molecular docking and antiepileptic evaluation., 29 (14): [PMID:31084949] [10.1016/j.bmcl.2019.05.007] |
Source
Source(1):